KIORA PHARMACEUTICALS, INC. Proceeds from Long-Term Debt Issued
KIORA PHARMACEUTICALS, INC. (KPRX) reported Proceeds from Long-Term Debt Issued of $0 for the 12-month period ending 2021-12-31, per its 10-K/A filed 2022-07-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2023-03-23
- KIORA PHARMACEUTICALS, INC. proceeds from issuance of long-term debt for the quarter ending 2020-12-31 was $0.00.
- KIORA PHARMACEUTICALS, INC. proceeds from issuance of long-term debt for the quarter ending 2020-09-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. proceeds from issuance of long-term debt for the quarter ending 2019-12-31 was $0.00.
- KIORA PHARMACEUTICALS, INC. proceeds from issuance of long-term debt for the quarter ending 2019-09-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. proceeds from issuance of long-term debt for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- KIORA PHARMACEUTICALS, INC. proceeds from issuance of long-term debt for fiscal 2020 was $278.19K.
- KIORA PHARMACEUTICALS, INC. proceeds from issuance of long-term debt for fiscal 2019 was $0.00.
| Period end | Proceeds from Issuance of Long-term Debt 1 month | Proceeds from Issuance of Long-term Debt 1 month as first filed | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K/A · filed 2022-07-07 | |||||
| 2020-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-07 | $0.00 derived: sum of 2 quarters · filed 2022-07-07 | $278.19K 10-K/A · filed 2022-07-07 | |||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $278.19K 10-Q · filed 2021-11-15 | ||||
| 2020-06-30 | $278.19K 10-Q · filed 2021-08-12 | |||||
| 2020-05-31 | $300.00K 10-K · filed 2023-03-23 | $278.00K 10-Q · filed 2020-08-06 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $0.00 derived: sum of 2 quarters · filed 2021-03-25 | $0.00 10-K · filed 2021-03-25 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | ||||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |